Sphere Fluidics Ltd, which is developing single cell analysis systems for biopharma research, has appointed Kenneth Hitchner as chairman of its board of directors. Mr Hitchner is an experienced financial executive having spent much of his 28-year career at Goldman Sachs in the biopharmaceutical and medical device sectors. He is currently a board member of Wuxi Biologics and CStone Pharmaceuticals Co Ltd, both of China.
Sphere Fluidics announced the appointment on 2 May 2023.
Copyright 2023 Evernow Publishing Ltd